Clinical trial
Myoinositol Therapy May Adjust The Metabolic Deregulation in Infertile Polycystic Ovarian Syndrome (PCOS) Women Through Modulation of The TyG Index-BMI: A Comparative Study Versus Metformin
NCT07058675 is registered in ClinicalTrials.gov with Benha University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myoinositol Therapy May Adjust The Metabolic Deregulation in Infertile Polycystic Ovarian Syndrome (PCOS) Women Through Modulation of The TyG Index-BMI: A Comparative Study Versus Metformin
- Lead sponsor
- Benha University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 25, 2024
- Completion date
- June 18, 2025
- Enrollment
- 156 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pcos